WuXi PharmaTech
Chinese public (bio)pharmaceutical, medical device and pharmaceutical services company
Nº Q8038871 ★★★
Rare · Organisations
WuXi PharmaTech
Chinese public (bio)pharmaceutical, medical device and pharmaceutical services company
WuXi AppTec Co., Ltd. (WuXi is pronounced as Wu-shee) is a Chinese provider of contract research, development, and manufacturing, services for the pharmaceutical and life-sciences industry, headquartered in Shanghai, China. The company operates research and manufacturing facilities in Asia, North America, and Europe.
Dernier prix
—
Prix plancher
—
Médiane 7 j
—
Ventes 30 j
0
Fourchette 30 j
—
En circulation
0
Cours
médiane
min – max
ventes
Aucune vente sur la période
Voir le tableau
| Date | médiane | Min | Max | ventes |
|---|
Historique des ventes
- Dernière vente
- —
- Moyenne 30 j
- —
- Plus bas 30 j
- —
- Plus haut 30 j
- —
- Ventes 7 j
- 0
- Ventes 30 j
- 0
Aucune vente pour l'instant.
Ventes anonymes : ni acheteur ni vendeur. Les chiffres ne comptent que les ventes entre joueurs.
Sur Wikipédia
Texte en anglais Pas encore d'article dans ta langue : extrait en anglais.
WuXi AppTec Co., Ltd. (WuXi is pronounced as Wu-shee) is a Chinese provider of contract research, development, and manufacturing, services for the pharmaceutical and life-sciences industry, headquartered in Shanghai, China. The company operates research and manufacturing facilities in Asia, North America, and Europe. Founded in 2000 by chemist Ge Li as WuXi PharmaTech, the company expanded through acquisitions and re‑listings in 2018 after a 2015 take‑private. It produces a large part of the ingredients used in treatments for illnesses including leukemia, lymphoma, HIV, and obesity. As of 2025, the company reported around 39,000 employees and 6,000 customers. Its clients have included Jiangsu Hengrui, GlaxoSmithKline, AstraZeneca and Pfizer.
Texte : Wikipédia en anglais, CC BY-SA 4.0. ·
